• Streptavidin-Cy3 Workflows for NPC Metastasis Studies

  2026-09-01

  Streptavidin-Cy3 converts biotinylated antibodies and nucleic acid probes into bright spatial or flow-cytometric readouts. This guide adapts the reagent to nasopharyngeal carcinoma studies, with practical workflows for validating seRNA-NPCm and NDRG1 localization, optimizing signal, and troubleshooting background.

• GW 6471: A Practical PPARα Antagonist Workflow

  2026-09-01

  GW 6471 enables causal testing of whether PPARα activity drives lipid imbalance, transcriptional responses, and toxicant-associated liver injury. This workflow connects receptor antagonism with orthogonal molecular, biochemical, and morphological readouts for cellular metabolism research and environmental disease modeling.

• Ferrocenyl Novobiocin Derivatives: Activity and Design

  2026-08-31

  The reference study developed ferrocenyl and organic novobiocin derivatives to address the need for new antimalarial and anticancer chemotypes. In vitro screening against Plasmodium falciparum 3D7 and HCC38 breast cancer cells showed that ferrocene incorporation generally improved activity, while also revealing scaffold- and substituent-dependent exceptions.

• Aurora Kinase A in High-Risk Retinoblastoma

  2026-08-30

  The 2024 American Journal of Pathology study identifies AURKA overexpression as a recurrent feature of human retinoblastoma and links it to histopathologic factors associated with aggressive disease and poor chemotherapy response. By combining patient-tissue analysis with genetic, pharmacologic, ex vivo, and xenograft models, the work supports AURKA–MYCN signaling as a testable therapeutic vulnerability rather than a purely descriptive biomarker.

• Sulfamonomethoxine: Applied Research Workflows

  2026-08-29

  Sulfamonomethoxine supports controlled antimicrobial, aquaculture, veterinary, and environmental-fate experiments when solvent handling and biodegradation controls are designed carefully. This workflow-oriented guide translates aerobic granular sludge findings into practical assay choices while separating validated evidence from starting-point recommendations.

• Tobramycin: From Ribosome Mechanism to Translation

  2026-08-29

  Tobramycin is more than a standard aminoglycoside antibiotic: it is a mechanistically defined perturbation tool for studying bacterial protein synthesis, susceptibility, and resistance phenotypes. This thought-leadership guide connects ribosomal biology with assay design, comparator interpretation, reagent strategy, and translational decision-making.

• Cabozantinib in RCC: From Kinase Blockade to Adaptation

  2026-08-28

  Cabozantinib (XL184) is more than a broad-spectrum kinase inhibitor: it is a useful perturbation tool for studying how tumor signaling changes over time. This thought-leadership analysis connects its RTK pharmacology with phosphoproteomic evidence from renal cell carcinoma, practical assay design, and translational strategies for modeling chronic drug adaptation.

• PBS Liposomes: Controls for Macrophage Studies

  2026-08-28

  Learn how PBS Liposomes, SKU K2722, help separate clodronate-specific macrophage depletion from effects caused by liposome handling, uptake, or experimental variation. This scenario-based guide covers control selection, assay interpretation, storage, workflow design, and vendor evaluation for reliable in vivo studies and related macrophage viability assays.

• Recombinant Human Growth Hormone Assay Guide

  2026-08-27

  Build more reproducible chondrocyte proliferation, differentiation, and pathway experiments with a defined somatotropin reagent. This guide connects dose-response design to the IGFBP2–THBS1–IGF-1 mechanism while providing practical controls for reconstitution, storage, and assay troubleshooting.

• miR-18a, ALOXE3, and Glioblastoma Ferroptosis

  2026-08-27

  Yang et al. identify a miR-18a/ALOXE3 axis that links lipid metabolism, ferroptosis resistance, and migration in glioblastoma. The study shows that ALOXE3 loss promotes tumor growth through p53-SLC7A11-dependent ferroptosis suppression and increases 12-HETE-driven activation of a Gs protein–PI3K-Akt cell signaling pathway.

• PYR-41 and the Hidden Logic of Protein Turnover

  2026-08-26

  E1 inhibition is more than a protein-degradation strategy: it is a way to interrogate how proteostasis shapes inflammatory and antiviral signaling. This thought-leadership guide connects PYR-41 mechanistic data with IRF7 biology, experimental design, and translational decision-making while clearly defining its preclinical limitations.

• Epinephrine Bitartrate: Assay Workflows

  2026-08-26

  Epinephrine Bitartrate gives researchers a controllable way to activate α- and β-adrenergic receptors in cell-based, pharmacology, and translational cardiovascular models. This guide converts receptor potency, canine pharmacokinetic evidence, and formulation constraints into practical workflows for reproducible adrenergic assays.

• Fucoidan and the Gut–Liver Axis in Chemotherapy Injury

  2026-08-25

  A 2026 study identifies intestinal barrier failure, lipopolysaccharide translocation, and hepatic neutrophil extracellular traps as a connected mechanism in irinotecan-induced steatohepatitis. It further shows that Fucoidan can preserve gut barrier integrity, moderate microbiota disruption, and reduce NET-associated liver inflammation in a mouse model.

• Saquinavir Workflow for HIV Protease Research

  2026-08-25

  Build more reproducible HIV protease inhibition assays with Saquinavir while using biomimetic chromatography to separate membrane-partitioning questions from enzyme potency. The workflow combines practical stock preparation, orthogonal permeability modeling, and troubleshooting guidance for antiretroviral drug research and translational studies.

• PPP1R3G/PP1γ Control RIPK1 Cell Death

  2026-08-24

  This study identifies PPP1R3G as a regulatory subunit that recruits PP1γ to dephosphorylate and activate RIPK1, thereby promoting RIPK1-dependent apoptosis and type I necroptosis. Genetic, biochemical, pharmacological, and mouse experiments connect this phosphatase mechanism to protection from TNF-induced systemic inflammation.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page